US Open tennis finals, the Manchester derby and Solheim Cup – follow with us

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-11 • Permanent link

Rumors of a measles outbreak in the United States have been circulating, but the recent decision by the Centers for Disease Control and Prevention (CDC) to question two measles deaths in Pennsylvania has sent shockwaves through the market. The CDC's handling of the outbreak has sparked concerns about the agency's accuracy, particularly in light of the growing measles crisis. Pharmaceutical stocks like Merck and Pfizer plummeted 5% and 3% respectively, while investors scrambled to make sense of the sudden shift in the market. The Dow Jones Industrial Average dropped 200 points, wiping out billions of dollars in value.

Investors are breathing a sigh of relief as the CDC's decision to question the measles deaths appears to have been a misstep. However, the damage has already been done, and the market is still reeling from the uncertainty. Consumers are likely to feel the pinch, as prices for vaccines and related products may rise in response to the growing measles crisis. The economic impact of the outbreak will be felt for months to come, with the CDC's reputation hanging in the balance.

Measles has been a persistent problem in the United States for decades, with outbreaks occurring every few years. The CDC's handling of the outbreak has been criticized in the past, with some experts arguing that the agency's response has been too slow and too little. The recent decision to question the measles deaths has only added fuel to the fire, with many calling for greater transparency and accountability from the CDC. As the measles crisis continues to unfold, it remains to be seen how the CDC will respond to the growing criticism.

As the measles crisis continues to simmer, investors are already looking to the future for signs of recovery. The CDC is expected to release new data on the outbreak in the coming weeks, which could provide some clarity on the situation. In the meantime, investors will be watching the market closely, looking for signs of a rebound. With the measles crisis showing no signs of abating, the road to recovery will be long and arduous, but it is a journey that investors will be eager to see unfold.